Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 2011

View Archived Issues

Monoclonal antibody recognizes human embryonic stem cells with teratoma-forming potential

FDA provides draft guidelines on medical device approval and biomarker qualification

Omecamtiv mecarbil improves cardiac function in phase II study

Scientists isolate broadly neutralizing antibodies against HIV

New corticotropin-releasing factor CRF1 receptor antagonists disclosed

Swiss research team prepares novel chemokine CXCR7 receptor agonists

NovaDel signs agreement with Rechon Life Science for Zolpimist

FDA approves FISH-based in vitro diagnostic test for chronic lymphocytic leukemia

Allergan patents new cannabinoid CB2 receptor agonists

Novel epidermal growth factor receptor inhibitors synthesized by Chinese company

Chinese teams disclose new protein kinase inhibitors

Vertex presents novel protein kinase C inhibitors

Health Canada accepts NDS for lurasidone

Phase II trial of Adcetris in CD30-positive non-Hodgkin's lymphoma begins

Helsinn Therapeutics enrolls first patient in anamorelin phase III program

Mayo Clinic receives grant to investigate genetic risk of heart and blood vessel diseases

Thermo Fisher Scientific acquires Phadia

EP-217609 obtains European orphan drug status

Vernalis begins dosing in phase I trial of Parkinson's disease candidate

FDA sets PDUFA date for Amgen's sBLA for Xgeva

BiondVax Pharmaceuticals commences new phase II study of Multimeric-001 influenza vaccine

BMS submits applications in Japan for additional indications for two anticancer drugs

Recruitment begins in phase III Botox trial in patients with stroke

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...